EUDAMED Status Update 2021
The development and deployment of EUDAMED is progressing. Following the implementation plan and getting familiar with the information stored in the database's modules is crucial for economic operators compliance in the EU market.
Liliana Teles

Liliana Teles

Regulatory Affairs Manager

EUDAMED is the IT system developed by the European Commission to implement Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnosis medical devices.

The system database is multipurpose, interoperable and structured around 6 interconnected modules and a public website:

  • Actor Registration – ACT
  • Unique Device Identification/Devices Registration – UDI
  • Notified Bodies and Certificates – CRF
  • Clinical Investigations and Performance Studies – CIPS
  • Vigilance and Post-Market Surveillance – VGL
  • Market Surveillance – MSU

What is stored in the EUDAMED?

Module ACT – Actor Registration

This module allows actors – manufacturers, system & procedure pack producers, importers and EU authorised representatives – to register. When an economic operator has submitted its actor registration request, the selected relevant national competent authority issues the Actor ID/ Single Registration Number (SRN) generated by EUDAMED, after approving the registration request. Actors are clearly identified through the SRN. After registration and verification of the data provided, the actors will have access to EUDAMED. 

Since the 1st December 2020 all actor information registered in EUDAMED are publicly available.

At the moment the European Commission is not in a position to require the use of the Actor registration module until EUDAMED is fully functional according to the Medical Device Regulation and additional national requirements on registrations can therefore not be excluded.

Module UDI – Unique Device Identification/Devices Registration

The UDI module contains all device-specific information. The UDI data is divided into BASIC UDI-DI and the UDI-DI. The BASIC UDI-DI serves to map all common properties of a product group. The UDI-DI contains only the product-specific information. 

As an economic operator, you are responsible for managing all UDI attributes in your own company and transferring the data to EUDAMED.

Information on the registered Basic UDI-DI, UDI-DI and Device are publicly available.

Module CRF – Notified Bodies and Certificates

Certificates issued by Notified Bodies on Quality Management System and Conformity Assessment in accordance with MDR 2017/745 and IVDR 2017/746 are stored in this module. The module is used to enable communication between the Notified Bodies and to monitor the status of the consultation procedures for clinical evaluations.

Public access will be granted to the registration of certificates of conformity, their scope and validity period, as well as the reports of the Notified Bodies on the SSCP.

Module CIPS – Clinical Investigations and Performance Studies 

This module will be used to manage clinical investigation and performance evaluation data. Besides, applications for clinical performance studies and trials can be submitted, as well as clinical follow-ups and post-market product changes and reports.

Clinical Investigation Registration, Clinical Investigation Results Reporting and Publication are accessible to the public. Clinical Investigation Application Documents will potentially be accessible by the public.

Module VGL – Vigilance and Post-Market Surveillance 

Several reports can be submitted via the Vigilance Module: Periodic Safety Update Report (PSUR; Periodic Summary Reports (PSR) and Reporting of Serious Incidents and Field Safety Corrective Actions (FSCAs) and Field Safety Notices (FSNs). FSCAs are automatically distributed to the appropriate authorities after they are reported in the Vigilance Module. 

Partial public access for manufacturer incident reports and Field Safety Notices.

Module MSUMarket Surveillance

This module is designed to facilitate cooperation and coordination between competent authorities of EU Member States.

Public may access the summary of the results of the reviews and assessments of the market surveillance activities.

What is the state of play of the implementation of EUDAMED?

The development and deployment of EUDAMED is progressing:

The module on Actor Registration (first module) went live in December 2020.

The module on UDI/Device Registration (second module) and the module on Notified Bodies and Certificates (third module) are available since October 2021 except for the mechanism for scrutiny and the clinical evaluation consultation procedure (CECP) functionalities. 

The remaining three modules – Clinical Investigations and Performance Studies, Vigilance and Post-Market Surveillance and Market Surveillance – as well as the mechanism for scrutiny and the CECP will be launched when EUDAMED is fully operational in May 2022.

References: European Commission – Medical Devices – EUDAMED. Available at: https://ec.europa.eu/health/md_eudamed/overview_en

further
reading

drug_device_combination_1
medical devices

Regulatory Framework of Drug-Device Combination

The advances in technology continue to merge different types of products and the historical lines of separation between medical devices and medicinal products are getting thinner. Products combining medicinal products and medical devices are regulated either by Regulation (EU) 2017/745 (MDR) or by Directive 2001/83/EC.

Read More »
cosmetic products

SCCS Preliminary Opinion on Alpha-Arbutin and Beta-Arbutin

Alpha-arbutin and Beta-arbutin are used in cosmetic with antioxidant, bleaching and skin conditioning functions. Following concerns raised during discussion within the Working Group on Cosmetic Products and consequent call for data on these ingredients, the SCCS assessed the safety of Alpha-arbutin and Beta-arbutin in cosmetic products.

Read More »
cosmetic products

Request for SCCS Scientific Opinion on Citral

The European Commission requested the SCCS to assess whether the derived safe use levels for Citral by the application of the QRA2 based on the induction of skin sensitization is adequate to protect consumers. A period of 9 months was set for issuing the scientific opinion.

Read More »
cosmetic products

SCCS Scientific Advice on the Safety of Triclocarban and Triclosan

The European Commission Scientific Committee on Consumer Safety (SCCS) has published its preliminary version of the scientific advice on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products. The deadline for comments was set at 27 May 2022.

Read More »
cosmetic products

Cosmetic Regulation in the Andean Community

In the Andean Community (Bolivia, Colombia, Ecuador and Peru), cosmetic products are mainly regulated by Decision 833. All cosmetic products made available in these countries must undergo a Mandatory Sanitary Notification (NSO) and need to be manufactured according to Good Manufacturing Practices (GMP).

Read More »
cosmetic products

Cosmetic Product Labelling in the European Union

The Regulation (EC) No 1223/2009 lays down the mandatory information that needs to be included in the packaging and container of a cosmetic products. In addition to this information, most cosmetic products include certain claims, which must be supported and properly substantiated.

Read More »
cosmetic products

Environmental Claims in the UK

Green claims are a trend among consumer goods and services. We often see claims like ‘clean beauty’, ‘environmental friendly’ and so many others. But how can companies ensure that these claims are not misleading? The UK’s Competition and Markets Authority (CMA) has published its Green Claims Code, in order to help companies comply with legal obligations when making environmental claims.

Read More »
cosmetic products

Parabens in Cosmetic Products

Parabens are widely used as preservatives in cosmetic and personal care products. Over the years, there have been some concerns related to the safety of parabens. The SCCS has published several opinions regarding the use of these ingredients in cosmetics, indicating the concentration levels they considered safe for human health. In the EU, some parabens can be safely used as preservatives, while others are prohibited in cosmetic products.

Read More »
cosmetic products

The Product Information File (PIF)

A Product Information File (PIF) is mandatory for all cosmetic products placed in the European Union market. It is a document that compiles the technical information of the cosmetic product and it must be kept for a period of 10 years by the Responsible Person.

Read More »